Multiple Sclerosis Library

Stem Cells May Be Key to Multiple Sclerosis Treatment

Tuesday, May 20th, 2014

Article from Liberty Voice by Bryan Jones on May 17, 2014. New research released in the journal Stem Cell Reports suggests that stem cell therapy may be the key to treating patients with multiple sclerosis (MS). Currently, there are few medically-accepted treatments for MS, and these only help with symptoms in the early stages of […]

Read More…

Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.

Monday, May 9th, 2011

Autoimmune Dis. 2010 Dec 15;2011:164608. Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Witherick J, Wilkins A, Scolding N, Kemp K. Multiple Sclerosis and Stem Cell Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol BS16 1LE, UK. Abstract Although significant advances have recently been […]

Read More…

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

Monday, May 9th, 2011

Curr Opin Immunol. 2010 Dec;22(6):768-74. Epub 2010 Nov 17. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Uccelli A, Prockop DJ. Department of Neurosciences Ophthalmology and Genetics, University of Genoa, Italy. auccelli@neurologia.unige.it Abstract The adult stem/progenitor cells from bone marrow and other tissues referred to as mesenchymal stem cells or multipotent mesenchymal stromal cells […]

Read More…

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Monday, May 9th, 2011

Stem Cell Rev. 2010 Dec; 6(4) : 548-59 Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Kemp K, Gray E, Mallam E, Scolding N, Wilkins A Abstract Increasing evidence suggests that bone marrow derived-mesenchymal stem cells (MSCs) have neuroprotective properties and a major mechanism of action is through their […]

Read More…

A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it’s time!

Monday, May 9th, 2011

2010 Dec;6(4):500-6. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it’s time! Siatskas C, Payne NL, Short MA, Bernard CC. Monash immunology and stem cell laboratories, Monash University, Clayton, Victoria, 3800, Australia. christopher.siatskas@monash.edu Abstract Multiple sclerosis is a neurodegenerative disease of the central nervous system that is characterized by inflammation, demyelination with […]

Read More…

Stem cells as therapeutics for neurodegenerative disorders?

Monday, May 9th, 2011

Stem cells as therapeutics for neurodegenerative disorders? Mattson MP. Laboratory of Neurosciences, National Institute on Aging GRC 4F01, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA. mattsonm@grc.nia.nih.gov Abstract Aging is associated with a progressive increase in the risk of several prominent neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, stroke and amyotrophic lateral sclerosis. […]

Read More…

Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter?

Monday, May 9th, 2011

Curr Stem Cell Res Ther. 2010 Oct 18. [Epub ahead of print] Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter? Uccelli A, Morando S, Bonanno S, Bonanni I, Leonardi A, Mancardi G. Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa. auccelli@neurologia.unige.it Abstract The lack of therapies fostering remyelination and regeneration […]

Read More…

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

Monday, May 9th, 2011

J Neuroimmunol. 2010 Oct 8; 227(1-2) : 185-9. Epub 2010 Aug 21. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R, Kreidieh NM, El-Sabban M, Bazarbachi A. Departments of Internal […]

Read More…

Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.

Monday, May 9th, 2011

Ann Hematol. 2010 Sep 25; Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Xu J, Ji BX, Su L, Dong HQ, Sun WL, Wan SG, Liu YO, Zhang P, Liu CY Abstract To evaluate clinical outcomes of autologous peripheral blood […]

Read More…

The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood derived stem cells.

Monday, May 9th, 2011

Cell Transplant. 2010 Sep 30. doi: 10.3727/096368910X532855. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood derived stem cells. Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD, Allickson JG, Cruz LE, Borlongan CV. Center Of Excellence for Aging and Brain Repair, Dept. Neurosurgery and Brain Reapir, University of […]

Read More…